These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25374888)

  • 1. H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1?
    Haubner R; Maschauer S; Einsiedel J; Eder IE; Rangger C; Gmeiner P; Virgolini IJ; Prante O
    Biomed Res Int; 2014; 2014():243185. PubMed ID: 25374888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo biokinetic and metabolic characterization of the ⁶⁸Ga-labelled α5β1-selective peptidomimetic FR366.
    D'Alessandria C; Pohle K; Rechenmacher F; Neubauer S; Notni J; Wester HJ; Schwaiger M; Kessler H; Beer AJ
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):953-963. PubMed ID: 26497698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
    Haubner R; Wester HJ; Reuning U; Senekowitsch-Schmidtke R; Diefenbach B; Kessler H; Stöcklin G; Schwaiger M
    J Nucl Med; 1999 Jun; 40(6):1061-71. PubMed ID: 10452325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.
    Knetsch PA; Petrik M; Griessinger CM; Rangger C; Fani M; Kesenheimer C; von Guggenberg E; Pichler BJ; Virgolini I; Decristoforo C; Haubner R
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1303-12. PubMed ID: 21487838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
    Yang J; Guo H; Miao Y
    Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
    Nock BA; Maina T; Krenning EP; de Jong M
    J Nucl Med; 2014 Jan; 55(1):121-7. PubMed ID: 24287321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
    Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
    J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
    Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
    J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.
    Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R
    Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
    Sancey L; Ardisson V; Riou LM; Ahmadi M; Marti-Batlle D; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2037-47. PubMed ID: 17674000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors.
    Ma Y; Liang S; Guo J; Guo R; Wang H
    J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
    Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
    Haubner R; Wester HJ; Weber WA; Mang C; Ziegler SI; Goodman SL; Senekowitsch-Schmidtke R; Kessler H; Schwaiger M
    Cancer Res; 2001 Mar; 61(5):1781-5. PubMed ID: 11280722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
    Hausner SH; Bauer N; Sutcliffe JL
    Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of malignant melanoma using 18F-labeled metallopeptides.
    Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
    J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.
    Jiang L; Kimura RH; Miao Z; Silverman AP; Ren G; Liu H; Li P; Gambhir SS; Cochran JR; Cheng Z
    J Nucl Med; 2010 Feb; 51(2):251-258. PubMed ID: 20124048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
    Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.